Background. Public health agencies suggest targeting ''hotspots'' to identify individuals with undetected HIV infection. However, definitions of hotspots vary. Little is known about how best to target mobile HIV testing resources. Methods. We conducted a computer-based tournament to compare the yield of 4 algorithms for mobile HIV testing. Over 180 rounds of play, the algorithms selected 1 of 3 hypothetical zones, each with unknown prevalence of undiagnosed HIV, in which to conduct a fixed number of HIV tests. The algorithms were: 1) Thompson Sampling, an adaptive Bayesian search strategy; 2) Explore-then-Exploit, a strategy that initially draws comparable samples from all zones and then devotes all remaining rounds of play to HIV testing in whichever zone produced the highest observed yield; 3) Retrospection, a strategy using only base prevalence information; and; 4) Clairvoyance, a benchmarking strategy that employs perfect information about HIV prevalence in each zone. Results. Over 250 tournament runs, Thompson Sampling outperformed Explore-then-Exploit 66% of the time, identifying 15% more cases. Thompson Sampling's superiority persisted in a variety of circumstances examined in the sensitivity analysis. Case detection rates using Thompson Sampling were, on average, within 90% of the benchmark established by Clairvoyance. Retrospection was consistently the poorest performer. Limitations. We did not consider either selection bias (i.e., the correlation between infection status and the decision to obtain an HIV test) or the costs of relocation to another zone from one round of play to the next. Conclusions. Adaptive methods like Thompson Sampling for mobile HIV testing are practical and effective, and may have advantages over other commonly used strategies.
poor at predicting which locales and groups may have high density of undiagnosed HIV. 14, 15 Mobile HIV testing using vans or other forms of community outreach are widely used to supplement testing at fixed sites and have been promoted by the CDC and the World Health Organization (WHO). 16, 17 Mobile testing can be particularly effective in reaching some of the highest-risk populations. 16, 18, 19 However, practitioners often rely on subjective recommendations from local public health officials, the staff of testing programs, and clients who have received testing services in the past to make decisions about where to test in outreach-and community-based settings. 16 Mobile testing units frequently target areas where the prevalence of HIV or AIDS was high when last estimated 20 (P. Stonehouse, Chicago Department of Health, personal communication). We know of no research on how to optimize the deployment of mobile HIV testing services.
The question of where to target HIV testing can be usefully portrayed as an ''exploration-exploitation dilemma'', a classic problem in the field of sequential decision making under uncertainty. 21 The decision maker who seeks to maximize long-run gains must strike a balance between deploying resources to improve knowledge of the prevailing circumstances and making the best possible use of whatever is already known about the current circumstances. Bandit algorithms are named for onearmed bandits (slot machines) and the choices a gambler must make in deciding which machines to play, for how often, and in which sequence to maximize winnings after observing the payouts from the machines played in the past. These algorithms provide a systematic way of solving exploitation-exploration problems. 22 Although bandit methods have been applied successfully to problems in fields ranging from military searches to oilfield exploration and online advertising, their use in the realm of public health and medical practice is limited. [23] [24] [25] [26] [27] This study assessed the effectiveness and efficiency of several strategies, including a bandit algorithm, for targeting mobile HIV testing, under conditions similar to those encountered in urban epidemics with different proportions of undiagnosed cases of HIV infection.
Methods

Analytic Overview
We conducted a computer-based tournament to compare the performance of 4 approaches to targeted mobile HIV testing in a hypothetical setting consisting of several geographic zones, each with unknown prevalence of undetected HIV infection. In each round of play, a strategy was required to designate a single zone in which to conduct a fixed number of HIV tests. Prior to each round of play, the strategy was permitted to assess the results of its testing activities in prior rounds. Performance was measured by the total number of HIV cases newly detected by a given strategy over multiple rounds of play. A secondary outcome was the magnitude of a strategy's average margin of success in finding new cases over other strategies.
HIV Infection and Geographic Zones
For the main analysis, we assumed that there were 3 zones (i 2 {1,2,3}) and T = 180 rounds of play, hereinafter referred to as days (reflecting the ease and plausibility with which mobile testing facilities can be relocated from one day to the next). Before the first day, we initialized the simulation by assigning different numbers of infected and uninfected persons (denoted by U i (0) and I i (0), respectively) to each zone. These were further separated into observed infected OI i (0) and unobserved infected UI i (0) individuals, while the uninfected population was composed of observed uninfected OU i (0) and unobserved uninfected UU i (0) individuals. This gave rise to 2 useful measures of prevalence:
, the population prevalence of HIV infection in zone i on day t; and UI i (t) UI i (t) + UU i (t) , the prevalence of HIV infection in zone i among persons whose HIV infection status is unknown on day t (which we label the undiagnosed prevalence, UP i (t).)
The undiagnosed prevalence UP i (t) value was used to determine the results of HIV testing on each day. If m HIV tests were conducted in zone i on day t, we determined the number of newly identified cases, X i (t), by sampling m times from a binomial probability distribution with success probability UP i (t). This reflects the simplifying assumption that tests were only conducted on persons whose HIV-infection status was unknown. It also reflects the simplifying assumption of sampling with replacement, that is; UP i (t) was established at the beginning of day t and remained unaltered by any screening that took place in that zone i on that day. (In reality, every HIV test produces an instantaneous change in the underlying prevalence of undetected infection. Our simplification is justified so long as the number of tests m conducted on a given day and in a given zone i was far smaller than the number of unobserved infections UI i (t) in that zone.) At the end of each day, we updated the unobserved prevalence to:
Underlying undiagnosed prevalence UP i (t) was assumed to change in 2 additional ways: 1) observed uninfected individuals could return to the pool of unobserved uninfected individuals after a specified period, reflecting the declining reliability and relevance of a negative result with the passage of time; and 2) new arrivals (both unobserved-infected and unobserved-uninfected) could enter the population.
Strategy 1: Thompson Sampling (TS)
TS is a Bayesian approach that simultaneously explores and exploits, choosing the course of action that maximizes expected future rewards based on random sampling from probability distributions that are themselves based upon prior probability distributions and observation. [28] [29] [30] TS is distinguished from the other strategies by: a) updating probabilities about the prevalence of undetected HIV infection, based on the observed results of its HIV testing activities; and b) the use of randomization to choose a zone based on those probabilities. Prior to the first day of play, the TS algorithm employs a Beta(a i , b i ) probability distribution for the prevalence of undiagnosed HIV among individuals in zone i at time t = 0. The Beta distribution is a continuous distribution on the interval (0,1) and is conjugate to the binomial distribution (i.e., the posterior distribution is beta when the likelihood is binomial and the prior is beta).
TS selects a zone i for testing, prior to each day, by sampling from each zone's current probability distribution for undetected HIV prevalence and then choosing the zone with the largest value. TS makes its selection without sampling from the zones themselves; rather, sampling is conducted on the undetected HIV prevalence distributions for each zone. Every zone has a non-zero probability of being selected for testing on any given day; but the probability that a given zone will be selected is aligned with prior estimates about the prevalence of undetected HIV infection in that zone. Once a zone is selected for testing on a given day, testing commences in that zone. The results of the tests from that day are used to update the probabilities for that zone: if the process of screening m persons in zone i on the first day produces x new cases detected, the posterior probability will follow a Beta (a i + x, b i + (m-x)) distribution. This updated distribution becomes the sampling distribution for zone selection for the second day (see Appendix for more details).
Strategy 2: Explore-then-Exploit (ETE)
This algorithm splits the total number of days of play in 2: an initial, exploratory phase (number of zones times t explore ), during which ETE samples in equal measures from all zones; and a subsequent exploitation phase, during which ETE devotes all remaining days to HIV testing in whichever zone produced the highest observed yield during the exploratory phase. This is in contrast to TS, which explores and exploits on an ongoing, adaptive basis. There is some flexibility in the number of days ETE may devote to exploration; more days dedicated to initial sampling increases the algorithm's power to detect the most promising zone but reduces the number of days remaining to exploit that information. We considered alternative exploratory periods in sensitivity analysis. Once the initial exploration period is over and a zone has been chosen for the exploitation phase, the ETE strategy stops ''learning'' and never ''changes its mind'', no matter how poorly it subsequently performs in its selected zone.
Strategy 3: Retrospection
The literature suggests that many jurisdictions deploy their mobile HIV testing resources based on historical information about where the greatest number of new cases of HIV infection were identified in the past 20 (P. Stonehouse, Chicago Department of Health, personal communication). The Retrospection strategy thus always chooses the zone with the highest previously estimated HIV prevalence for testing on any given day.
Strategy 4: Clairvoyance
The Clairvoyance strategy has access to perfect information about the prevalence of undiagnosed HIV infection in each geographic area on every day. The performance of this strategy provides an upper-bound benchmark of what could be achieved by testing only in the zone with the highest actual prevalence of undiagnosed HIV infection on any given day. 24 The Clairvoyance strategy only has perfect information about the prevalence of undetected HIV infection in a given zone; it does not have any special knowledge about the HIV-infection status of individuals within that zone. Thus, it can select the most promising zone within which to conduct HIV screening activities but it cannot guarantee that individuals selected for screening within that zone will be infected (that is, the strategy samples with replacement on all individuals regardless of actual infection status).
Parameter Definitions, Main Analysis and Sensitivity Analyses
Initial parameter values as well as those used in the sensitivity analyses are described in Tables 1 and 2 . We did not base the parameter values on data from a specific region or country, choosing instead to understand how the 4 strategies described above would perform in a variety of circumstances. We explored values ranging from 0.05% to 6.75% for the underlying prevalence of undiagnosed HIV infection. The low value reflects epidemics, like those in the US, where overall HIV prevalence is low and most (.85%) people know their HIV status; the higher value represents epidemics where HIV prevalence is high as are undiagnosed infections, such as in South Africa. 1, 2, 31, 32 We assumed there was no correlation between estimated HIV prevalence in a previous year and the current prevalence of undiagnosed HIV infection in each zone. We made this assumption because high prevalence in and of itself does not indicate that a location has a high number of undiagnosed individuals. Settings with older epidemics and successful testing programs (New York State, for example) may have many HIVinfected individuals but few individuals with undiagnosed HIV infection. 33 In addition, several authors have described the limitations of using prevalence surveys and the lack of consensus on how best to locate undiagnosed cases. 34, 35 Finally, estimating prevalence in geographic areas with small numbers of people in the at-risk population can be challenging. 36 For these reasons, we did not use previous year's HIV prevalence in a zone as a one-toone surrogate for the current year's prevalence of undiagnosed HIV infection. However, if the estimated HIV prevalence did correlate with the prevalence of undiagnosed HIV infection, the Retrospection strategy would perform as a partial Clairvoyance strategy, knowing the rank order of zones to test in on the first day of the simulation, but being unable to account for shifts in the underlying prevalence on subsequent days.
We considered different rates of population movement, setting in-migration of new HIV-negative individuals between 5 to 12 per day in each zone in the main analysis, to reflect fast-growing settings. We also considered a case with no in-migration in the sensitivity analysis. We chose 45 days as the baseline ''shelf life'' of an HIV-negative test result, after which the observed negative case returned to the unobserved, uninfected pool. 37, 38 We chose 180 days (range, 100 to 1000 days) for the main analysis number of days of testing, to represent a midyear review of the strategy for a hypothetical decision maker who might be evaluating new approaches for targeting HIV testing. In the main analysis, the number of tests per day (m) was set at 25; we explored values from 10 to 40 tests per day in the sensitivity analysis. 18, 39 In the main analysis, zones were assigned HIV incidence rates ranging from 0.5 to 1 infection per day; we considered values from 0 to 3.5 in the sensitivity analysis, reflecting static epidemics and ones where incidence is still high. 40 We chose a value of 30 days of exploration in each zone in the main analysis for the ETE strategy. This period was selected to represent the number of days a decision maker might be willing to defer a choice about a testing program's location. In the sensitivity analyses, we examine values ranging from 5 to 45 days, to represent decision makers who have varying degrees of flexibility or patience in terms of making choices about the deployment of resources. If we had required the ETE strategy to base its decision on a sample size calculation with assumptions about power (e.g., 1-b = 0.90) and significance or Type I error probability (e.g., a = 0.05) and adjusted for multiple comparisons using the same historical data on HIV prevalence figures used by the Retrospection strategy as baseline predictions, the exploratory phase would have exceeded 1,800 rounds of play.
For the TS strategy, we applied uniform, uninformative Beta(a = 1, b = 1) distributions to represent prior beliefs about the underlying prevalence of HIV infection in all 3 zones. This permitted us to evaluate TS in a setting where we have virtually no information about the prevalence of undiagnosed HIV infection in any of the zones. Of course, there is a great deal of existing information about the AIDS epidemic in the US and in other countries, which would allow us to construct more informative prior probabilities. To that end, in the sensitivity analyses, we evaluated TS with 2 other Beta distributions common across all zones: Beta (0.1, 9.9) and Beta (1, 99), both of which assume a mean prevalence of undiagnosed HIV infection across all the zones of 1% with sample sizes of 10 and 100, respectively. This 1% figure was chosen based on an assumption that the prevalence of unobserved HIV + individuals in each zone is less than the existing HIV prevalence. 41 We ran the tournament 250 times with any given set of data assumptions. All performance statistics reported in the next section represent averages across these 250 runs. If a strategy outperformed another in a head-tohead comparison with greater than or equal to 55.25% of the wins in 250 simulations, we reported this result as significant. This 55.25% figure was derived from a onesided Z-test of a difference in proportions, where 0.5525 is the threshold for a difference in proportions with a P value of less than 0.05.
Results
Main Analysis
In the main analysis, Clairvoyance outperformed all other strategies in overall number of new HIV diagnoses. TS (and ETE) identified 90% (and 84%) as many new infections as Clairvoyance, whereas Retrospection found just 50% (Figure 1) . In a head-to-head comparison, TS outperformed ETE 65.9% of the time, with an average margin of victory of 18.6 new cases; in the 31.7% of instances where ETE outperformed TS, the margin of Figure 2 ; there were some ties so values do not sum to 100%).
Sensitivity Analysis
We re-evaluated all findings using the data ranges specified in Tables 1 and 2 . Generally, overall win percentages and average margins of victory remained stable under the tested parameter values (Table 3) . However, the win differential between ETE and TS vanished when any of the following changes were made: the overall prevalence of undetected HIV in the population was reduced below 1%; the prevalence differential between zones was reduced; or fewer than 10 tests were performed per day. ETE and TS also had no significant difference (P . 0.05) in wins when we increased the number of days of testing above 1,000; here however, the average margin of victory for TS against ETE was far larger than the average margin of victory for ETE against TS. The performance of TS was improved when it employed more informative priors with larger sample sizes: using prior belief distributions Beta (1, 99) increased its win percentage against ETE from 65.8% to 69.1%. The performance of ETE was improved when it spent fewer days in the initial ''exploratory'' phase. When ETE sampled for 5 days (rather than 30 days) in each zone, its win percentage rose from 31.7% to 42.6%. However, less exploration also introduced greater volatility into ETE's performance, increasing its average margins of both wins and losses.
Discussion
In the literature, more complex bandit approaches have been discussed in the context of clinical trial design, the allocation of resources from the national strategic stockpile for influenza outbreaks and the design of mHealth apps. [42] [43] [44] [45] [46] We know of no work that has used TS or other bandit algorithms to improve the performance of mobile HIV testing or to operationalize the focus on hotspots of HIV, or to improve the detection and diagnosis of other infectious or chronic diseases. However, other approaches to sequential decision making under uncertainty, of which bandit algorithms are a part, such as adaptive sampling and Markov decision processes, have been explored in health. 47, 48 Our results suggest that TS is a practical and effective approach to locating highyield locations for HIV testing. TS outperformed ETE in the main analysis and in all but a few circumstances in the sensitivity analysis and detected only 10% fewer cases than could be achieved using a benchmark Clairvoyance strategy with access to perfect information. The performance of TS in the main analysis is consistent with evaluations of TS versus similar ETE approaches in the sequential decision making literature. 28, 30 In fact, evidence that TS performs better as the number of arms increases in an experiment suggests that the head-to-head superiority of TS against ETE should increase with additional geographic zones in the simulation. 43, 49, 50 Sensitivity analyses indicate that TS performs best when geographic zones differ greatly in their prevalence of undetected HIV. Importantly, when the underlying prevalence of undiagnosed HIV infection is low, all strategies perform poorly. This may make TS less useful in the general population in the US, where relatively few people are living with undiagnosed HIV infection, and more appropriate for wide use in countries with more severe epidemics. This also suggests that TS may be particularly suited to communities in the US and elsewhere, where HIV infection is thought to be heterogeneously distributed and ''hotspots'' are believed to exist. TS could be targeted to assist in choosing among locations (e.g., gay social venues), where prevalence and/or incidence may be higher than in the general population and where risk among these special locations varies as well. [51] [52] [53] A particularly attractive feature of the TS algorithm is its simplicity of implementation and the ease with which it can be updated in real time. At the end of each day, the staff need only make note of the zone visited, the number of tests performed, and the number of new cases detected.
Our study has several limitations. We considered only 3 zones for HIV testing; in reality, decision makers must often choose from among large numbers of possible locations. We conceived of zones as distinct geographical areas; in practice, ''hotspots'' may have both a geographic and a temporal component (e.g., an area with many nightclubs may only be a hotspot late on Fridays and Saturdays). And we did not account for potential correlations between adjacent zones in their prevalence of undetected HIV, although this would not be a factor in our example that used only 3 zones. We also did not account for the possibility of differential rates of uptake in testing within zones. For example, it is possible that there is a correlation between risk of infection (or infection status) and an individual's decision to obtain an HIV test. Although we opted for simplicity in our assessment of mobile HIV testing, our approach is flexible enough to accommodate the elaborations discussed above and to adapt to more complicated forms of immigration, emigration depletion, and both the endogenous and exogenous forces that might cause a hotspot to cool off. We did not account for the costs of switching zones, though we expect the costs of moving a mobile unit from one location to another would be low. Additionally, whereas HIV + individuals in different settings sometimes get re-tested after an initial diagnosis, we assumed all tests were conducted on people whose HIV status was unknown. 54, 55 If we had relaxed this assumption, repeated testing would have reduced the effectiveness of each program, but would have no effect on the relative yield of different algorithms, and therefore, no effect on our findings and conclusions. Finally, the use of the binomial approximation in a setting of sampling without replacement may not be justified if the number of undiagnosed cases of HIV infection is low or the overall population size is small. In that situation, the number of tests per day would quickly exhaust the pool of undiagnosed cases. However, there are algorithms that implement TS without replacement, utilizing a hypergeometric prior and a beta-binomial posterior. 56 These weaknesses notwithstanding, TS offers a practical means of managing the exploration-exploitation tradeoff and could be an important new tool to improve the detection of HIV in a community, to increase the rate of linkage to care, and to reduce the number of secondary HIV infections caused by those who are unaware of their HIV status. To assess the effectiveness of TS versus alternative strategies in real settings, we plan to test the algorithm in the US and in South Africa in cluster randomized designs similar to those used to evaluate case finding strategies for HIV and other infectious diseases. 57, 58, 59 Supplementary Material
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